(lp0
S"Tetraphase Pharmaceuticals Inc Is Climbing Again Today -- Here's Why Motley Fool - Mar 10, 2017 Shares of Tetraphase Pharmaceuticals Inc , a clinical-stage biotech developing antibiotics, continued its impressive climb with another gain of about 15.8%, as of 11:46 a.m."
p1
aS'Tetraphase Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 17 Equities.com - 18 hours ago Tetraphase Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock gained 5.21% to close at $8.28.Tetraphase Pharmaceuticals Inc  Cut to Sell at Zacks Investment Research - BNB Daily Tetraphase Pharmaceuticals, Inc.  Touches into Overbought RSI Levels - Aiken Advocate'
p2
aS'Analyst Activity  Stifel Nicolaus Raises Its Price Target On Tetraphase ... Market Exclusive - Mar 9, 2017 Tetraphase Pharmaceuticals, Inc.  is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections.Tetraphase Pharmaceuticals Inc  Sees Large Volume Increase on Analyst ... - BNB Daily Analyst Hints Surrounding Tetraphase Pharmaceuticals, Inc.  - Post Analyst'
p3
aS"Tetraphase Pharmaceuticals, Ionis Pharmaceuticals, Facebook Stocks Moving Today Schaeffers Research  - Mar 10, 2017 The S&amp;P is set to snap a six-week winning streak, with traders turning their attention to next week's Fed decision after a blowout jobs report."
p4
aS'Tetraphase Pharmaceuticals Inc.  Soars 14.31% on March 10 Equities.com - Mar 10, 2017 Tetraphase Pharmaceuticals Inc.  had a good day on the market for Friday March 10 as shares jumped 14.31% to close at $6.95.'
p5
aS'Tetraphase Pharmaceuticals Inc.  Breaks into New 52-Week High on March ... Equities.com - Mar 14, 2017 Shares of Tetraphase Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $7.98. Shares closed at $7.59 after opening at $7.95 for a move of -2.32%.'
p6
aS"Tetraphase Pharmaceuticals Doses First Patient in IGNITE3 Phase 3 Clinical ... GlobeNewswire  - Jan 17, 2017 WATERTOWN, Mass., Jan. 17, 2017  -- Tetraphase Pharmaceuticals, Inc.  today announced dosing of the first patient in IGNITE3, the Company's phase 3 clinical trial evaluating the efficacy and safety of once-daily&nbsp;..."
p7
aS'Tetraphase Pharmaceuticals Reports Second Quarter 2016 Financial Results and ... GlobeNewswire  - Aug 4, 2016 04, 2016  -- Tetraphase Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant  infections, today reported financial results for ...'
p8
aS'Hynes Keller &amp; Hernandez, LLC Announces Investigation of Tetraphase ... PR Newswire  - Jun 23, 2016 NEW YORK, June 23, 2016 /PRNewswire/ -- Hynes Keller &amp; Hernandez, LLC is investigating potential claims against the Board of Directors of Tetraphase Pharmaceuticals Inc.   concerning possible breaches&nbsp;...'
p9
aS"Today's Research Reports on Biotech Stocks to Watch: Inotek Pharmaceuticals ... Yahoo Finance - Mar 13, 2017 NEW YORK, NY / ACCESSWIRE / March 13, 2017 / For biotech pharmaceutical companies, the FDA approval process is beyond critical for the financial health of the company and its stakeholders. Getting fast tracked by the FDA is a significant boost. Most of&nbsp;..."
p10
a.